Parkinsonism and psychopathology severity in real-world outpatients with schizophrenia: A cross-sectional PRISM study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Extrapyramidal symptoms (EPS) have been described as intrinsic to schizophrenia spectrum disorders (SSD), beyond medication-induced effects. Among EPS, parkinsonism is the most prevalent subtype and has been linked to poorer clinical and functional outcomes. We aimed to examine the relationships between parkinsonism and psychopathology and social functioning, as well as its demographic and pharmacological correlates, in a real-world sample of outpatients with schizophrenia receiving stable antipsychotic medication. Data were drawn from the PRISM project, an EU-funded, multicentre, cross-sectional, naturalistic study. Parkinsonism was assessed with the Extrapyramidal Symptoms Rating Scale (ESRS). Patients aged 18–45 years with a confirmed DSM-IV diagnosis of schizophrenia were included if clinically stable on unchanged antipsychotic dosage for ≥ 8 weeks and excluded if scoring > 22 on the PANSS-Positive subscale or ≥ 4 on the ESRS. Associations were analysed using correlation and regression models adjusted for relevant covariates, including antipsychotic exposure. Ninety patients were included (mean age 31.53 ± 6.64 years; 36.7% female; 27.8% “other than White”). Parkinsonism prevalence was 51% (ESRS≥1), higher among “other than White” participants (80% vs. 40%, χ 2 p < 0.001). Parkinsonism was not significantly associated with antipsychotic dose, route, or generation, nor with concomitant psychotropic use (all p > 0.05). Parkinsonism severity correlated with PANSS-Positive ( rₛ = 0.228, p = 0.031), PANSS-Negative ( rₛ = 0.278, p = 0.008), PANSS-General ( rₛ = 0.210, p = 0.047), and PANSS-Total ( rₛ = 0.283, p = 0.007). In adjusted regression models, associations remained significant for PANSS-Negative ( β = 0.276, p = 0.019) and PANSS-Total ( β = 0.234, p = 0.043). No significant associations were observed with social functioning. These findings suggest that parkinsonism is closely associated with clinical symptom severity and may reflect core illness-related features of schizophrenia.
Source: Schizophrenia Research
Institutions: Universidad Complutense de Madrid, King's College London, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, Leiden University Medical Center, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, University of Groningen, Hospital Universitario La Paz, Hospital La Paz Institute for Health Research
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: parkinsonism, extrapyramidal symptoms
Open Access status: hybrid
Estimated APC paid: $3,910
Awards: G2514089353, G2703413578, G390664091, Hacia una intervención estratificada en psiquiatría: Predicción de trayectorias de riesgo y resiliencia para la salud mental en una muestra transdiagnóstica de jóvenes (proyecto PREMY)., Interacciones genes-ambiente en las trayectorias de salud mental de los jóvenes, G4569372835, G6806569120, G7920099057, G8155430728, G842865865, G8560727560, Estudio longitudinal de una cohorte representativa: superando la heterogeneidad clínica y biológica en primeros episodios psicóticos, The impact of social isolation on aging health in schizophrenia
OpenAlex ID: W7207776451
